Poster Session 2026

- Home
- Amanda N. D. Adams
- Olivia Ambrose
- Prooksa Ananchuensook
- Victoria H Anderson
- Mariam Baig
- Suchandra Banerjee
- Ofri Bar
- Leah C Beauchamp
- Paige K Berger
- Chandrima Bhattacharya
- Katy Bond
- Camille Briskin
- Amanda Darling
- Mengxi Du
- Guilherme Fahur Bottino
- Elsa Fristot
- Emmanuel A Gyimah
- Erik Hasenoehrl
- Kyoo Heo
- Nathan T Jacobs
- Jordan S L Jensen
- Yehoon Jo
- Da Jung Jung
- Roka Kakehi
- Thomas M Kuntz
- S. Li
- Valeria Lugo Mesa
- Xochitl C Morgan
- Jacob T Nearing
- Ana Nogal
- Maribel Okiye
- Wakako Okuda
- Lily A Palumbo
- Yiming Shi
- Jack T Sumner
- Vishnu Thayil Valappil
- Chahat Upreti
- Maggie Viland
- Dongyu Wang
- Ya Wang
- Xinyu Wang
- Yan Yan
- Yiyan Yang
Poster Session 2026
Dynamics of the oropharyngeal microbiome are associated with clinical outcomes in allogeneic stem cell transplantation
Presented By: Yan Yan
Oropharyngeal upper respiratory tract (URT) infections are a common complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT), yet it remains poorly understood how the oropharyngeal URT microbiome contributes to clinical outcomes. In a prospective cohort of 156 recipients, we longitudinally profiled oropharyngeal metagenomes alongside antibiotic exposure and immune profiles. High-risk antibiotics were associated with depletion of endogenous microbes in favor of pathogen dominance, including Enterococcus faecium and Burkholderia cenocepacia. Mediation analysis linked high-risk antibiotic exposure specifically to loss of Prevotella melaninogenica, a modulator of CD8⁺ effector/memory T cells, whose carriage correlated with improved progression-free survival. We identified five reproducible oropharyngeal URT community types, including a newly emerged post-HSCT Burkholderiaceae-enriched cluster that was linked to adverse aGvHD event. A classifier integrating microbial and immune features improved progression prediction in patients with low antibiotic exposure. These findings provide a systematic characterization of the URT microbiome and highlight it as a potential biomarker of HSCT outcomes.